This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

CVS foreclosed competitor access to independent pharmacies, US House report finds

( January 21, 2026, 20:17 GMT | Official Statement) -- MLex Summary: The US House Judiciary Committee released an interim staff report finding that CVS Health stifled innovation by threatening independent pharmacies that work with potential competitors. According to the report, CVS changed its network rules to stop independent pharmacies from working with hubs, used audits and cease-and-desist letters against independent pharmacies to foreclose competitor access and restrict options for independent pharmacies, and leveraged its pharmacy beneficiary manager network to eliminate competition.Statement follows in full. Also see attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections